TP53 and Cerebral ischemia: Because multiple studies have suggested that SIRT1 can decrease cellular and tissue injury by such mechanisms as decreasing acetylation of p53 and NFκB, it is reasonable to expect that SIRT1 may produce beneficial effects in cerebral ischemia.